Identification of novel peroxisome proliferator-activated receptor α (PPARα) target genes in mouse liver using cDNA microarray analysis

Gene Expression

Volumn 9, Issue 6, 2001, Pages 291-304

  Cherkaoui Malki, M ^a   Meyer, K ^a   Cao, W Q ^a   Latruffe, N ^b   Yeldandi, A V ^a   Rao, M S ^a   Bradfield, C A ^c   Reddy, J K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Liver DNA microarray analysis; Peroxisome proliferator; Peroxisome proliferator activated receptor (PPAR )

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ACYLGLYCEROL LIPASE; ANTILIPEMIC AGENT; CARCINOGEN; CD24 ANTIGEN; CD39 ANTIGEN; CELL DEATH INDUCING DNA FRAGMENTATION FACTOR ALPHA; CELL MEMBRANE PROTEIN; COMPLEMENTARY DNA; CYTOCHROME P450 2B10; CYTOCHROME P450 2B9; CYTOCHROME P450 ISOENZYME; FIBRIC ACID DERIVATIVE; GLUCOSE; LIPID; LIPOCORTIN 2; LYMPHOCYTE ANTIGEN 6; MESSENGER RNA; PEROXISOMAL BIOGENESIS FACTOR 11BETA; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOTRANSFERASE; PIRINIXIC ACID; PYRUVATE DEHYDROGENASE KINASE 4; RETINOIC ACID EARLY TRANSCRIPT GAMMA; RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOGENESIS; CELL CYCLE; CONTROLLED STUDY; DNA MICROARRAY; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GLUCOSE METABOLISM; LIPID METABOLISM; LIVER; LIVER CANCER; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PEROXISOME; UNINDEXED SEQUENCE;

ANIMALIA; EUKARYOTA;

EID: 0035184941     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000001783992533     Document Type: Article

References (80)

1. Comparative sequence analysis of gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6
2. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis
3. PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene
4. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin
5. Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity
6. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
7. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion
8. Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes
9. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
10. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
11. Reversible alteration of hepatic messenger RNA species for peroxisomal and non-peroxisomal proteins induced by hypolipidemic drug Wy-14,643
12. Proteomic analysis of differential protein expression in primary hepatocytes induced by EGF, tumor necrosis factor α or the peroxisome proliferator nafenopin
13. PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
14. A Ufd2/D4Colele chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse
15. Peroxisome proliferator-activated receptor α-dependent induction of cell surface antigen Ly-6D gene in the mouse liver
16. Isolation of a new mouse cDNA clone: Hybrid form of cytochrome P450 2b10 and NADPH-cytochrome P 450 oxidoreductase
17. Cloning and transcriptional regulation of a novel adipocyte-specific gene, FSP27. CAAT-enhancer-binding protein (C/EBP) and C/EBP-like proteins interact with sequences required for differentiation-dependent expression
18. Peroxisomes (microbodies and related particles)
19. Peroxisome proliferatoractivated receptors: Nuclear control of metabolism
20. The PPARα-leukotriene B 4 pathway to inflammation control
21. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
22. Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas
23. Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene
24. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase
25. A null mutation in murine CD 36 reveals an important role in fatty acid and lipoprotein metabolism
26. Complete structure of the murine p36 (annexin II) gene. Identification of mRNAs for both the murine and the human gene with alternatively spliced 5′ noncoding exons
27. CD24 is a marker for human breast carcinoma
28. A comparative study of the effects of clofibrate, ciprofibrate, WY14,643, and di-(2-ethylhexyl)-phthalate on liver protein expression in mice
29. Mechansims of action of the nongenotoxic peroxisome proliferators: Role of the peroxisome proliferator-activated receptor
30. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression
31. Tissue expression, structure and function of the murine Ly-6 family of molecules
32. Defect in peroxisome proliferator-activated receptor α inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
33. Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype
34. PPAR agonists reduce 11-hydroxystreoid dehydrogenase type 1 in the liver
35. Peroxisome proliferator-induced long chain acyl-CoA thioesterases comprise a highly conserved novel multi-gene family involved in lipid metabolism
36. Characterization of the 70-kDa peroxisomal membrane protein, an ATP binding cassette transporter
37. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor
38. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
39. Differential expression of the peroxisome proliferator-activated receptor γ (PPARγ) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse
40. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation
41. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases
42. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
43. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
44. Solution structure of the CIDE-N domain of CIDE-B and a model for CIDE-N/CIDE-N interactions in the DNA fragmentation pathway of apoptosis
45. Peroxisomal lipid degradation via β- and α-oxidation in mammals
46. Expression of human MutS homolog 2 (hMSH2) protein in resting and proliferating cells
47. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators
48. 3-Hydroxy-3-methylglutaryl-CoA synthase. Participation of acetyl-S-enzyme and enzyme-S-hydroxymethylgutaryl-SCoA intermediates in the reaction
49. Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-a-)p-chlorophenoxyisobutyrate, a peroxisome proliferator
50. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner
51. Peroxisome proliferator activated receptor α expression in human liver
52. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine
53. Peroxisome proliferatoractivated receptors, coactivators, and downstream targets
54. Peroxisome proliferation and hepatocarcinogenesis
55. Hepatocarcinogenesis of peroxisome proliferators
56. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
57. Peroxisome proliferator-induced pleiotropic responses: Pursuit of a phenomenon
58. Peroxisomal β-oxidation and PPARα: An adaptive metabolic system
59. Hepatic peroxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate
60. Carcinogenesis by hepatic proxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to human
61. Peroxisomal lipid metabolism
62. Peroxisome proliferator-activated receptor mediates induction of the mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase gene by fatty acids
63. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
64. Expression of PEX11β mediates peroxisome proliferation in the absence of extracellular stimuli
65. Cell proliferation and apoptosis in normal liver and preneoplastic liver foci
66. 11β-hydroxysteroid dehydrogenase type 1 - A tissue-sepecific amplifier of glucocorticoid action
67. Regulation of apo A-I gene expression by fibrates
68. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress
69. The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain of CD36
70. Pexllp plays a primary role in medium-chain fatty acid oxidation, a process that affects peroxisome number and size in Saccharomyces cerevisiae
71. Peroxisomes, lipid metabolism and human disease
72. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, clofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate
73. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor y activation has coordinate effects on gene expression in multiple insulin-sensitive tissues
74. The genes for a mouse hematopoietic differentiation marker called the heat-stable antigen
75. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: The case of murine and human Ly-6 proteins
76. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
77. An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression
78. Identification of a peroxisome proliferatorresponsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase
79. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms
80. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: A novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules